Clinical trial
Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B…
NCT00047827 · Astellas Pharma Inc, Industry · Terminated
Key facts
| NCT number | NCT00047827 |
|---|---|
| Title | Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis |
| Official title | A Phase 2, Open-Label, Non-Comparative Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) as First-Line Therapy in the Treatment of Invasive Aspergillosis |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aspergillosis |
| Intervention type | Drug |
| Interventions | Micafungin, Liposomal Amphotericin B |
| Enrollment | 2 |
| Start date | Dec 1, 2002 |
| Primary completion | Feb 1, 2003 |
| Completion | Feb 1, 2003 |
| First posted | Oct 24, 2002 |
| Last update posted | Aug 20, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: